DocGo (DCGO)
NASDAQ:DCGO
DCGO Stock Chart & Stats
$0.52
-$0.06(-1.42%)
At close: 4:00 PM EST
$0.52
-$0.06(-1.42%)
Day’s Range― - ―
52-Week Range$0.52 - $2.51
Previous CloseN/A
Volume125.49K
Average Volume (3M)1.22M
Market Cap
$51.33M
Enterprise Value$29.49M
Total Cash (Recent Filing)$51.02M
Total Debt (Recent Filing)$29.18M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
May 11, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.37
Shares Outstanding98,750,250
10 Day Avg. Volume1,255,445
30 Day Avg. Volume1,219,603
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.60
Price to Sales (P/S)0.27
P/FCF Ratio3.22
Enterprise Value/Market Cap0.57
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit0.30
Enterprise Value/Ebitda-0.40
Forecast
1Y Price Target
$2.38Price Target Upside357.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$298.91M
Bulls Say, Bears Say
Bulls Say
Payor Relationships And Service MixGrowing payor relationships combined with a unique mix of virtual care and in-home nursing makes the company an attractive partner for health plans seeking cost savings.
Revenue MomentumVolume growth in core transportation and mobile health is driving revenue momentum and contributed to results that beat expectations.
Strategic AcquisitionThe SteadyMD acquisition expanded virtual care revenue and demonstrates effective strategic execution supporting growth in telehealth services.
Bears Say
Liquidity And Working Capital PressureDelays in collecting receivables from migrant services and working capital demands have reduced cash balances, raising concerns about near-term liquidity and the need for further cash management.
Migrant-contract ImpactMigrant-related contracts temporarily inflated revenue while introducing additional costs and operational complexity that obscure underlying performance.
Organic Revenue WeaknessExcluding the acquired virtual care business, organic mobile health revenue appears to be declining, indicating slower ramp in core payer and provider segments.
DocGo News
DCGO FAQ
What was DocGo’s price range in the past 12 months?
DocGo lowest stock price was $0.52 and its highest was $2.51 in the past 12 months.
What is DocGo’s market cap?
DocGo’s market cap is $51.33M.
When is DocGo’s upcoming earnings report date?
DocGo’s upcoming earnings report date is May 11, 2026 which is in 28 days.
How were DocGo’s earnings last quarter?
DocGo released its earnings results on Mar 16, 2026. The company reported -$1.37 earnings per share for the quarter, missing the consensus estimate of -$0.142 by -$1.228.
Is DocGo overvalued?
According to Wall Street analysts DocGo’s price is currently Undervalued.
Does DocGo pay dividends?
DocGo does not currently pay dividends.
What is DocGo’s EPS estimate?
DocGo’s EPS estimate is -0.12.
How many shares outstanding does DocGo have?
DocGo has 98,750,250 shares outstanding.
What happened to DocGo’s price movement after its last earnings report?
DocGo reported an EPS of -$1.37 in its last earnings report, missing expectations of -$0.142. Following the earnings report the stock price went up 20.093%.
Which hedge fund is a major shareholder of DocGo?
Currently, no hedge funds are holding shares in DCGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DocGo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.38 (357.69% Upside)
$2.38 (357.69% Upside)
Blogger Sentiment
Bullish
DCGO Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 5.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.2%
Last 30 Days ▲ 13.2%
Last 30 Days ▲ 13.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-79.24%
12-Months-Change
Fundamentals
Return on Equity
-71.45%
Trailing 12-Months
Asset Growth
-50.81%
Trailing 12-Months
Company Description
DocGo
DocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.
DCGO Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational momentum and several concrete positive developments — raised 2026 revenue and adjusted EBITDA guidance, strong performance from SteadyMD and remote patient monitoring, meaningful volume growth across core services, hiring progress, and a clear efficiency roadmap with measurable savings. Offsetting these positives were substantial noncash impairments, a material year-over-year revenue drop tied to the one-time wind-down of migrant programs, a decline in cash balance and delayed receivables (~$20M) that create near-term working capital and covenant considerations, and margin pressure from elevated overtime and lower-margin legacy programs. On balance the company presented actionable plans (staffing, automation, cost-savings, and strategic review) and an improved outlook for 2026, suggesting operational recovery and path to adjusted EBITDA profitability later in the year despite near-term liquidity and accounting headwinds.View all DCGO earnings summariesDCGO Stock 12 Month Forecast
Average Price Target
$2.38
▲(357.69% Upside)
Technical Analysis
Ownership Overview
7.09% Insiders
8.67% Mutual Funds
12.60% Other Institutional Investors
62.30% Public Companies and
Individual Investors